Global COVID 19 Impact On Vaccines & Drugs Market Overview
Vaccines are doses of killed microbes. They stimulate the immune systems of the body against that particular microbe, preventing the diseases. As the dead microbes of the disease are injected, the body develops resistance towards that particular type of microbe thus preventing the disease. Further, drugs are compounds that change the functioning of the consumer when inhaled. Thus, both vaccines and drugs are used to prevent and treat diseases. The rise in the number of infectious diseases across the globe including Swine Flu, Influenza, Ebola, hepatitis Tuberculosis, and more drives the market for vaccines and drugs.COVID-19 vaccines market accounted for US$ 2.6 billion in 2020 and is estimated to be US$ 1.5 billion by 2025 and is anticipated to register a CAGR of -10.4%
Global COVID 19 Impact On Vaccines & Drugs Market Dynamics
An increasing number of clinical trials
An increasing number of clinical trials drive the growth of the vaccine and drug market. For instance, on 17th April 2020, the National Medical Products Administration of China approved Two COVID-19 inactivated vaccines for phases 1 and 2 combined trials. Additionally, in March 2020, two major pharma companies, Pfizer and BioNTech declared a joint venture to co-develop and distribute coronavirus vaccine. Similarly, in April 2020, Johnson & Johnson proclaimed to produce to 900 million COVID-19 vaccines by the first quarter of 2021. Therefore, the outbreak of the pandemic has stirred share activity in the vaccine and drug market leading to its growth.
At present, about 155 molecules are under clinical investigation, and around 45 molecules are under preclinical development to be targeted against COVID-19. In which, four promising drugs have been repurposed for use against COVID-19.
- Remdesivir
- Chloroquine and hydroxychloroquine
- Ritonavir/lopinavir
- Ritonavir/lopinavir and interferon-beta
According to data published in June 2020, the National Institutes of Health (NIH) is planning late-stage studies for multiple COVID-19 vaccines. The NIH intends to start a phase 3 trial of Moderna’s vaccine in July 2020, followed by an August trial of AstraZeneca’s vaccine and a September study of Johnson & Johnson’s shot.
Funding from governments and foundations globally
Incentives are required to involve manufacturers for the large-scale capacity production in order to guarantee adequate production of SARS-CoV-2 vaccines.
Several global organizations have come forward to accelerate the process, such as CEPI, Gavi, and WHO. Still, witnessing the pandemic scenario of COVID-19, much stronger initiatives are needed. In April 2020, the Bill and Melinda Gates Foundation declared strategies to help fund factories for seven promising vaccines, even before seeing conclusive data. The purpose of the foundation is to scale up manufacturing during testing. Also the most promising Moderna program, various other big pharma companies are involved in COVID-19 vaccine work. Sanofi has two partnerships in its pipeline i.e. with the federal government and others with Translate Bio. Johnson & Johnson has promised a manufacturing scale-up to 1 billion doses for its federally partnered program.
However, stringent regulations and the lengthy approval procedure hampers the growth of the market during the forecast period.
Global COVID 19 Impact On Vaccines & Drugs Market Segmentation
The COVID-19 impact on vaccines & drugs market is segmented based on type, end-user, and region.
On the basis of the type, the COVID-19 impact on vaccines & drugs market is segmented into vaccines and drugs. Based on the end-user, the target market is segmented into hospitals, clinical, and others.
In the region, the COVID-19 impact on vaccines & drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the dominating region in terms of market share across the globe due to the presence of major pharma companies in the region that have the funds to develop the vaccine. Although, Asia-Pacific is also expected to register the highest growth rate / CAGR during the forecast period 2020-2026. This is mainly attributed due to growing populations and a rising number of cases coupled with early clinical trial approvals would provide lucrative growth prospects for the vaccine and drug market across the Asia-Pacific region.
|
Attribute |
Details |
|
The base year for estimation |
2019 |
|
Forecast period |
2019 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2019 – 2029 |
|
Market Segmentation |
By Type– Vaccine and Drugs By End-user– Hospitals, Clinical, and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the COVID-19 impact on vaccines & drugs market report based on type, end-user, and region.
COVID-19 Impact on Vaccines & Drugs Market, By Type:
- Vaccine
- Drugs
COVID-19 Impact on Vaccines & Drugs Market, By End-user:
- Hospitals
- Clinical
- Others
COVID-19 Impact on Vaccines & Drugs Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Global COVID 19 Impact On Vaccines & Drugs Market Key Players
The key players operating in the COVID-19 impact on vaccines & drugs market include Pfizer, Inc., Serum Institute of India, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Sanofi S.A, Gilead Sciences, Inc., Merck KGaA, and Janssen Pharmaceuticals, Inc. Major manufacturers in the biotech industry, including pharmaceutical companies and research organizations such as the National Institutes of Health (NIH), US, are being supported by governments to develop novel vaccines and drugs to combat this deadly virus. Currently, the players are engaged in the development of novel drugs for treating coronavirus include AbbVie Inc., BioCryst Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., and companies witnessing the development of vaccines as a preventive measure include Novavax, Inc. and Inovio Pharmaceuticals, Inc.
Global COVID 19 Impact On Vaccines & Drugs Market Company Profile
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Serum Institute of India
- Johnson & Johnson Services, Inc.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Sanofi S.A
- Gilead Sciences, Inc.
- Merck KGaA
- Janssen Pharmaceuticals, Inc.
“*” marked represents similar segmentation in other categories in the respective section
Global COVID 19 Impact On Vaccines & Drugs Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for COVID-19 Impact on Vaccines & Drugs Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By End-user
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market segmentation, By Type, 2019 – 2025, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 – 2025
- Y-o-Y Growth Analysis (%), 2019 – 2025
- Segment Trends
- Vaccine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2025
- Drugs
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2025
- Overview
- Market segmentation, By End-user, 2019 – 2025, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 – 2025
- Y-o-Y Growth Analysis (%), 2019 – 2025
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2025
- Clinics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2025
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2025
- Overview
- Global Market, By Region, 2019 – 2025, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 – 2025
- Y-o-Y Growth Analysis (%), 2019 – 2025
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Type, 2019 – 2025
- Market Size and Forecast (US$ Bn), By End-user, 2019 – 2025
- Market Size and Forecast (US$ Bn), By Country, 2019 – 2025
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Type, 2019 – 2025
- Market Size and Forecast (US$ Bn), By End-user, 2019 – 2025
- Market Size and Forecast (US$ Bn), By Country, 2019 – 2025
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Type, 2019 – 2025
- Market Size and Forecast (US$ Bn), By End-user, 2019 – 2025
- Market Size and Forecast (US$ Bn), By Country, 2019 – 2025
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Type, 2019 – 2025
- Market Size and Forecast (US$ Bn), By End-user, 2019 – 2025
- Market Size and Forecast (US$ Bn), By Country, 2019 – 2025
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Type, 2019 – 2025
- Market Size and Forecast (US$ Bn), By End-user, 2019 – 2025
- Market Size and Forecast (US$ Bn), By Country, 2019 – 2025
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Serum Institute of India
- Johnson & Johnson Services, Inc.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Sanofi S.A
- Gilead Sciences, Inc.
- Merck KGaA
- Janssen Pharmaceuticals, Inc.
- Pfizer, Inc.
- The Last Word
- Future Impact
- About Us
- Contact